<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35078730</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-8952</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>138</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</Title>
          <ISOAbbreviation>Clin Neurophysiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.</ArticleTitle>
        <Pagination>
          <StartPage>231</StartPage>
          <EndPage>240</EndPage>
          <MedlinePgn>231-240</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinph.2021.12.014</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1388-2457(22)00011-6</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the heterogeneity of electrodiagnostic (EDx) studies in Guillain-Barré syndrome (GBS) patients collected as part of the International GBS Outcome Study (IGOS).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Prospectively collected clinical and EDx data were available in 957 IGOS patients from 115 centers. Only the first EDx study was included in the current analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Median timing of the EDx study was 7 days (interquartile range 4-11) from symptom onset. Methodology varied between centers, countries and regions. Reference values from the responding 103 centers were derived locally in 49%, from publications in 37% and from a combination of these in the remaining 15%. Amplitude measurement in the EDx studies (baseline-to-peak or peak-to-peak) differed from the way this was done in the reference values, in 22% of motor and 39% of sensory conduction. There was marked variability in both motor and sensory reference values, although only a few outliers accounted for this.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study showed extensive variation in the clinical practice of EDx in GBS patients among IGOS centers across the regions.</AbstractText>
          <AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">Besides EDx variation in GBS patients participating in IGOS, this diversity is likely to be present in other neuromuscular disorders and centers. This underlines the need for standardization of EDx in future multinational GBS studies.</AbstractText>
          <CopyrightInformation>Copyright © 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Arends</LastName>
            <ForeName>Samuel</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Neurology, Haga Teaching Hospital The Hague, The Hague, the Netherlands. Electronic address: s.arends@erasmusmc.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drenthen</LastName>
            <ForeName>Judith</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: j.drenthen@erasmusmc.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van den Bergh</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University Hospital St-Luc, Brussels, Belgium. Electronic address: peter.vandenbergh@uclouvain.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Franssen</LastName>
            <ForeName>Hessel</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hadden</LastName>
            <ForeName>Robert D M</ForeName>
            <Initials>RDM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, King's College Hospital, London, United Kingdom. Electronic address: robert.hadden@nhs.net.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Islam</LastName>
            <ForeName>Badrul</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory Sciences and Services Division (LSSD), International Centre for Diarrhoeal Disease Research (icddr,b) Dhaka, Bangladesh. Electronic address: badrul.islam@icddrb.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuwabara</LastName>
            <ForeName>Satoshi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Chiba University Hospital, Chiba, Japan. Electronic address: kuwabara-s@faculty.chiba-u.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reisin</LastName>
            <ForeName>Ricardo C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Británico, Buenos Aires, Argentina. Electronic address: rcreisin@intramed.net.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shahrizaila</LastName>
            <ForeName>Nortina</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: nortina@um.edu.my.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amino</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Chiba University Hospital, Chiba, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antonini</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University, Sant'Andrea Hospital, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Attarian</LastName>
            <ForeName>Shahram</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department Neuromuscular Disorders, Hôpital de La Timone, Marseille, France. Electronic address: shahram.attarian@ap-hm.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Balducci</LastName>
            <ForeName>Claudia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barroso</LastName>
            <ForeName>Fabio</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Fleni Hospital, Buenos Aires, Argentina. Electronic address: fbarroso@fleni.org.ar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bertorini</LastName>
            <ForeName>Tulio</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The University of Tennessee Health Science Center, Memphis, USA. Electronic address: tbertori@uthsc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Binda</LastName>
            <ForeName>Davide</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Valduce Hospital, Como, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brannagan</LastName>
            <ForeName>Thomas H</ForeName>
            <Initials>TH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University, New York City, USA. Electronic address: tb2325@cumc.columbia.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Buermann</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University Hospital of Saarland, Homburg, Germany; Department of Neurology, MVZ Pfalzklinikum, Kusel, Germany. Electronic address: jan.buermann@mvz.pfalzklinikum.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Casasnovas</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Universitari de Bellvitge-IDIBELL and CIBERER, Barcelona, Spain. Electronic address: carloscasasnovas@bellvitgehospital.cat.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cavaletti</LastName>
            <ForeName>Guido</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy. Electronic address: guido.cavaletti@unimib.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chao</LastName>
            <ForeName>Chi-Chao</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: b1401019@ms17.hinet.net.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dimachkie</LastName>
            <ForeName>Mazen M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, The University of Kansas Medical Center, Kansas City, USA. Electronic address: mdimachkie@kumc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fulgenzi</LastName>
            <ForeName>Ernesto A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Cesar Milstein, Buenos Aires, Argentina. Electronic address: efulgenzi@intramed.net.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galassi</LastName>
            <ForeName>Giuliana</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University Hospital of Modena, Modena, Italy. Electronic address: giulianagalassi@alice.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gutiérrez Gutiérrez</LastName>
            <ForeName>Gerardo</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harbo</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: tharbo@dadlnet.dk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hartung</LastName>
            <ForeName>Hans-Peter</ForeName>
            <Initials>HP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University of Dusseldorf, Dusseldorf, Germany. Electronic address: hans-peter.hartung@uni-duesseldorf.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hsieh</LastName>
            <ForeName>Sung-Tsang</ForeName>
            <Initials>ST</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: shsieh@ntu.edu.tw.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kiers</LastName>
            <ForeName>Lynette</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Neurophysiology, Department of Neurology, The Royal Melbourne Hospital, Parkville, Australia. Electronic address: lynette.kiers@mh.org.au.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lehmann</LastName>
            <ForeName>Helmar C</ForeName>
            <Initials>HC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University Hospital of Cologne, Cologne, Germany. Electronic address: helmar.lehmann@uk-koeln.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manganelli</LastName>
            <ForeName>Fiore</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marfia</LastName>
            <ForeName>Girolama A</ForeName>
            <Initials>GA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of System Medicine, Dysimmune Neuropathies Unit, Policlinico Tor Vergata, Roma, Italy. Electronic address: marfia@uniroma2.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mataluni</LastName>
            <ForeName>Giorgia</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of System Medicine, Dysimmune Neuropathies Unit, Policlinico Tor Vergata, Roma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pardo</LastName>
            <ForeName>Julio</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain. Electronic address: julio.pardo.fernandez@sergas.es.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Péréon</LastName>
            <ForeName>Yann</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Neurophysiology, Reference Centre for Neuromuscular Disorders AOC, Filnemus, Euro-NMD, University of Nantes, Nantes, France. Electronic address: yann.pereon@univ-nantes.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rajabally</LastName>
            <ForeName>Yusuf A</ForeName>
            <Initials>YA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom. Electronic address: y.rajabally@aston.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santoro</LastName>
            <ForeName>Lucio</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy. Electronic address: lusantor@unina.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sekiguchi</LastName>
            <ForeName>Yukari</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Chiba University Hospital, Chiba, Japan. Electronic address: syukari536@chiba-u.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stein</LastName>
            <ForeName>Beth</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, St. Joseph's Regional Medical Center, Paterson, USA. Electronic address: steinb@sjhmc.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stettner</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: mark.stettner@uk-essen.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uncini</LastName>
            <ForeName>Antonino</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University "G. D'Annunzio", Chieti, Italy. Electronic address: uncini@unich.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verboon</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: j.verboon@erasmusmc.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verhamme</LastName>
            <ForeName>Camiel</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: c.verhamme@amsterdamumc.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vytopil</LastName>
            <ForeName>Michal</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Lahey Hospital and Medical Center, Burlington, MA, USA. Electronic address: michal.vytopil@lahey.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Waheed</LastName>
            <ForeName>Waqar</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University of Vermont Medical Centre, Burlington, USA. Electronic address: waqar.waheed@uvmhealth.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China. Electronic address: emgwangmin@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zivkovic</LastName>
            <ForeName>Sasha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, USA. Electronic address: zivksx@upmc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacobs</LastName>
            <ForeName>Bart C</ForeName>
            <Initials>BC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: j.drenthen@erasmusmc.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cornblath</LastName>
            <ForeName>David R</ForeName>
            <Initials>DR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Johns Hopkins University, Baltimore, MD, USA. Electronic address: dcornbl@jhmi.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>IGOS consortium</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Clin Neurophysiol</MedlineTA>
        <NlmUniqueID>100883319</NlmUniqueID>
        <ISSNLinking>1388-2457</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004568" MajorTopicYN="N">Electrodiagnosis</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020275" MajorTopicYN="Y">Guillain-Barre Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009431" MajorTopicYN="Y">Neural Conduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AIDP</Keyword>
        <Keyword MajorTopicYN="N">AMAN</Keyword>
        <Keyword MajorTopicYN="N">AMSAN</Keyword>
        <Keyword MajorTopicYN="N">Electromyography</Keyword>
        <Keyword MajorTopicYN="N">Nerve conduction studies</Keyword>
        <Keyword MajorTopicYN="N">Reference values</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Addington</LastName>
          <ForeName>J M</ForeName>
          <Initials>JM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ajroud-Driss</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Andersen</LastName>
          <ForeName>H</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Antonini</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Attarian</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Badrising</LastName>
          <ForeName>U A</ForeName>
          <Initials>UA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Balloy</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Barroso</LastName>
          <ForeName>F A</ForeName>
          <Initials>FA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Bateman</LastName>
          <ForeName>K</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Bella</LastName>
          <ForeName>I R</ForeName>
          <Initials>IR</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Benedetti</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van den Bergh</LastName>
          <ForeName>P</ForeName>
          <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Bertorini</LastName>
          <ForeName>T E</ForeName>
          <Initials>TE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Bhavaraju-Sanka</LastName>
          <ForeName>R</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Bianco</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Brannagan</LastName>
          <ForeName>T H</ForeName>
          <Initials>TH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Briani</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Buerrmann</LastName>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Busby</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Butterworth</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Casasnovas</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Cavaletti</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Chao</LastName>
          <ForeName>C C</ForeName>
          <Initials>CC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Chavada</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Chen</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Claeys</LastName>
          <ForeName>K G</ForeName>
          <Initials>KG</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Conti</LastName>
          <ForeName>M E</ForeName>
          <Initials>ME</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Cornblath</LastName>
          <ForeName>D R</ForeName>
          <Initials>DR</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Cosgrove</LastName>
          <ForeName>J S</ForeName>
          <Initials>JS</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Dalakas</LastName>
          <ForeName>M C</ForeName>
          <Initials>MC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Damme</LastName>
          <ForeName>P</ForeName>
          <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Dardiotis</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Davidson</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Derejko</LastName>
          <ForeName>M A</ForeName>
          <Initials>MA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Dijk</LastName>
          <ForeName>G W</ForeName>
          <Initials>GW</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Dimachkie</LastName>
          <ForeName>M M</ForeName>
          <Initials>MM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Doorn</LastName>
          <ForeName>P A</ForeName>
          <Initials>PA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Dornonville de la Cour</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Echaniz-Laguna</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Eftimov</LastName>
          <ForeName>F</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Faber</LastName>
          <ForeName>C G</ForeName>
          <Initials>CG</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fazio</LastName>
          <ForeName>R</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Feasby</LastName>
          <ForeName>T E</ForeName>
          <Initials>TE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fokke</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fujioka</LastName>
          <ForeName>T</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fulgenzi</LastName>
          <ForeName>E A</ForeName>
          <Initials>EA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Galassi</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Garcia-Sobrino</LastName>
          <ForeName>T</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Garssen</LastName>
          <ForeName>M P J</ForeName>
          <Initials>MPJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gijsbers</LastName>
          <ForeName>C J</ForeName>
          <Initials>CJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gilchrist</LastName>
          <ForeName>J M</ForeName>
          <Initials>JM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gilhuis</LastName>
          <ForeName>H J</ForeName>
          <Initials>HJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Goldstein</LastName>
          <ForeName>J M</ForeName>
          <Initials>JM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gorson</LastName>
          <ForeName>K C</ForeName>
          <Initials>KC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Goyal</LastName>
          <ForeName>N A</ForeName>
          <Initials>NA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Granit</LastName>
          <ForeName>V</ForeName>
          <Initials>V</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Grisanti</LastName>
          <ForeName>S T E</ForeName>
          <Initials>STE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gutiérrez-Gutiérrez</LastName>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gutmann</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hadden</LastName>
          <ForeName>R D M</ForeName>
          <Initials>RDM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Harbo</LastName>
          <ForeName>T</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hartung</LastName>
          <ForeName>H P</ForeName>
          <Initials>HP</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Holbech</LastName>
          <ForeName>J V</ForeName>
          <Initials>JV</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Holt</LastName>
          <ForeName>J K L</ForeName>
          <Initials>JKL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hsieh</LastName>
          <ForeName>S T</ForeName>
          <Initials>ST</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Htut</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hughes</LastName>
          <ForeName>R A C</ForeName>
          <Initials>RAC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Illa</LastName>
          <ForeName>I</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Islam</LastName>
          <ForeName>B</ForeName>
          <Initials>B</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Islam</LastName>
          <ForeName>Z</ForeName>
          <Initials>Z</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Jacobs</LastName>
          <ForeName>B C</ForeName>
          <Initials>BC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fehmi</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Jellema</LastName>
          <ForeName>K</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Jerico Pascual</LastName>
          <ForeName>I</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kaida</LastName>
          <ForeName>K</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Karafiath</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Katzberg</LastName>
          <ForeName>H D</ForeName>
          <Initials>HD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Khoshnoodi</LastName>
          <ForeName>M A</ForeName>
          <Initials>MA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kiers</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kimpinski</LastName>
          <ForeName>K</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kleyweg</LastName>
          <ForeName>R P</ForeName>
          <Initials>RP</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kokubun</LastName>
          <ForeName>N</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kolb</LastName>
          <ForeName>N A</ForeName>
          <Initials>NA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Koningsveld</LastName>
          <ForeName>R</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van der Kooi</LastName>
          <ForeName>A J</ForeName>
          <Initials>AJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kramers</LastName>
          <ForeName>J C H M</ForeName>
          <Initials>JCHM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kuitwaard</LastName>
          <ForeName>K</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kusunoki</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kuwabara</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kwan</LastName>
          <ForeName>J Y</ForeName>
          <Initials>JY</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ladha</LastName>
          <ForeName>S S</ForeName>
          <Initials>SS</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Landschoff Lassen</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lawson</LastName>
          <ForeName>V</ForeName>
          <Initials>V</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lehmann</LastName>
          <ForeName>H C</ForeName>
          <Initials>HC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lee Pan</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lunn</LastName>
          <ForeName>M P T</ForeName>
          <Initials>MPT</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Manji</LastName>
          <ForeName>H</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Marfia</LastName>
          <ForeName>G A</ForeName>
          <Initials>GA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Márquez Infante</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Martin-Aguilar</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Martinez Hernandez</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mataluni</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mattiazi</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>McDermott</LastName>
          <ForeName>C J</ForeName>
          <Initials>CJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Meekins</LastName>
          <ForeName>G D</ForeName>
          <Initials>GD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Miller</LastName>
          <ForeName>J A L</ForeName>
          <Initials>JAL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mohammad</LastName>
          <ForeName>Q D</ForeName>
          <Initials>QD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Monges</LastName>
          <ForeName>M S</ForeName>
          <Initials>MS</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Moris de la Tassa</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Nascimbene</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Navacerrada-Barrero</LastName>
          <ForeName>F J</ForeName>
          <Initials>FJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Nobile-Orazio</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Nowak</LastName>
          <ForeName>R J</ForeName>
          <Initials>RJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Orizaola</LastName>
          <ForeName>P J</ForeName>
          <Initials>PJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Osei-Bonsu</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Pardal</LastName>
          <ForeName>A M</ForeName>
          <Initials>AM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Pardo</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Pascuzzi</LastName>
          <ForeName>R M</ForeName>
          <Initials>RM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Péréon</LastName>
          <ForeName>Y</ForeName>
          <Initials>Y</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Pulley</LastName>
          <ForeName>M T</ForeName>
          <Initials>MT</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Querol</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Reddel</LastName>
          <ForeName>S W</ForeName>
          <Initials>SW</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van der Ree</LastName>
          <ForeName>T</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Reisin</LastName>
          <ForeName>R C</ForeName>
          <Initials>RC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rinaldi</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Roberts</LastName>
          <ForeName>R C</ForeName>
          <Initials>RC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rojas-Marcos</LastName>
          <ForeName>I</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rudnicki</LastName>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sachs</LastName>
          <ForeName>G M</ForeName>
          <Initials>GM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Samijn</LastName>
          <ForeName>J P A</ForeName>
          <Initials>JPA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Santoro</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Schenone</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sedano Tous</LastName>
          <ForeName>M J</ForeName>
          <Initials>MJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Shahrizaila</LastName>
          <ForeName>N</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sheikh</LastName>
          <ForeName>K A</ForeName>
          <Initials>KA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Silvestri</LastName>
          <ForeName>N J</ForeName>
          <Initials>NJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sindrup</LastName>
          <ForeName>S H</ForeName>
          <Initials>SH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sommer</LastName>
          <ForeName>C L</ForeName>
          <Initials>CL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Stein</LastName>
          <ForeName>B</ForeName>
          <Initials>B</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Song</LastName>
          <ForeName>Y</ForeName>
          <Initials>Y</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Stino</LastName>
          <ForeName>A M</ForeName>
          <Initials>AM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tankisi</LastName>
          <ForeName>H</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tannemaat</LastName>
          <ForeName>M R</ForeName>
          <Initials>MR</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Twydell</LastName>
          <ForeName>P</ForeName>
          <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Vélez-Santamaria</LastName>
          <ForeName>P V</ForeName>
          <Initials>PV</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Varrato</LastName>
          <ForeName>J D</ForeName>
          <Initials>JD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Vermeij</LastName>
          <ForeName>F H</ForeName>
          <Initials>FH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Visser</LastName>
          <ForeName>L H</ForeName>
          <Initials>LH</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Vytopil</LastName>
          <ForeName>M V</ForeName>
          <Initials>MV</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Waheed</LastName>
          <ForeName>W</ForeName>
          <Initials>W</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Walgaard</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Wang</LastName>
          <ForeName>Y Z</ForeName>
          <Initials>YZ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Willison</LastName>
          <ForeName>H J</ForeName>
          <Initials>HJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Wirtz</LastName>
          <ForeName>P W</ForeName>
          <Initials>PW</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Yamagishi</LastName>
          <ForeName>Y</ForeName>
          <Initials>Y</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Zhou</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Zivkovic</LastName>
          <ForeName>S A</ForeName>
          <Initials>SA</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>26</Day>
          <Hour>5</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35078730</ArticleId>
        <ArticleId IdType="doi">10.1016/j.clinph.2021.12.014</ArticleId>
        <ArticleId IdType="pii">S1388-2457(22)00011-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
